Revised SPC: Nerlynx (neratinib) 40 mg Film-coated Tablets
SPC has been revised to warn treatments that increase gastrointestinal pH may lower the absorption of neratinib, thus decreasing systemic exposure, thus co-administration with proton pump inhibitors is not recommended.
Source:
electronic Medicines compendium